2-106415860-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001144013.2(RGPD3):āc.5054A>Gā(p.Glu1685Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,459,688 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 27)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
RGPD3
NM_001144013.2 missense
NM_001144013.2 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 5.15
Genes affected
RGPD3 (HGNC:32416): (RANBP2 like and GRIP domain containing 3) This gene is located in a cluster of Ran-binding protein related genes on chromosome 2 which arose through duplication in primates. The encoded protein contains an N-terminal TPR (tetratricopeptide repeat) domain, two Ran-binding domains, and a C-terminal GRIP domain (golgin-97, RanBP2alpha, Imh1p and p230/golgin-245) domain. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD3 | NM_001144013.2 | c.5054A>G | p.Glu1685Gly | missense_variant | 21/23 | ENST00000409886.4 | NP_001137485.1 | |
RGPD3 | XM_017004738.2 | c.5078A>G | p.Glu1693Gly | missense_variant | 22/24 | XP_016860227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD3 | ENST00000409886.4 | c.5054A>G | p.Glu1685Gly | missense_variant | 21/23 | 1 | NM_001144013.2 | ENSP00000386588 | P2 | |
RGPD3 | ENST00000304514.11 | c.5036A>G | p.Glu1679Gly | missense_variant | 21/23 | 2 | ENSP00000303659 | A2 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD3 genomes
Cov.:
27
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459688Hom.: 0 Cov.: 40 AF XY: 0.00000138 AC XY: 1AN XY: 726154
GnomAD4 exome
AF:
AC:
1
AN:
1459688
Hom.:
Cov.:
40
AF XY:
AC XY:
1
AN XY:
726154
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 27
GnomAD4 genome
Cov.:
27
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2021 | The c.5054A>G (p.E1685G) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a A to G substitution at nucleotide position 5054, causing the glutamic acid (E) at amino acid position 1685 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Uncertain
.;D
Sift4G
Uncertain
D;D
Polyphen
0.99
.;D
Vest4
MutPred
0.20
.;Gain of MoRF binding (P = 0.0353);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.